PGR and breast carcinoma: With respect to postmenopausal users of HT, Cox regression analyses showed significant inverse associations with risks of ER+, HER2-, Ki67low, Bcl-2+ and p53- tumors, and a non-significant tendency for an inverse association with PR+ breast cancer (Additional file 2: Table S7).